Therapeutic Innovation for Multi-Resistant Candidemics: Synergy of Isavuconazole and Caspofungin Association
Abstract
Share and Cite
Duminuco, A.; Mauro, E.; Palumbo, G.A.M.; Garibaldi, B.; Parisi, M.; Di Raimondo, F.; Maugeri, C.; Vetro, C. Therapeutic Innovation for Multi-Resistant Candidemics: Synergy of Isavuconazole and Caspofungin Association. Hematol. Rep. 2021, 13, 9329. https://doi.org/10.4081/hr.2021.9329
Duminuco A, Mauro E, Palumbo GAM, Garibaldi B, Parisi M, Di Raimondo F, Maugeri C, Vetro C. Therapeutic Innovation for Multi-Resistant Candidemics: Synergy of Isavuconazole and Caspofungin Association. Hematology Reports. 2021; 13(4):9329. https://doi.org/10.4081/hr.2021.9329
Chicago/Turabian StyleDuminuco, Andrea, Elisa Mauro, Giuseppe A. M. Palumbo, Bruno Garibaldi, Marina Parisi, Francesco Di Raimondo, Cinzia Maugeri, and Calogero Vetro. 2021. "Therapeutic Innovation for Multi-Resistant Candidemics: Synergy of Isavuconazole and Caspofungin Association" Hematology Reports 13, no. 4: 9329. https://doi.org/10.4081/hr.2021.9329
APA StyleDuminuco, A., Mauro, E., Palumbo, G. A. M., Garibaldi, B., Parisi, M., Di Raimondo, F., Maugeri, C., & Vetro, C. (2021). Therapeutic Innovation for Multi-Resistant Candidemics: Synergy of Isavuconazole and Caspofungin Association. Hematology Reports, 13(4), 9329. https://doi.org/10.4081/hr.2021.9329